Team Continuous Glucose Monitoring (CGM) Study

 Back to Clinical Trials

Study Title: Team Support to Improve Glycemic Control Using CGM in Diverse Populations (TEAM CGM)

PI/Lead Researcher: Paul Pirraglia, MD

IRB#: 2084870

NCT#: NCT05911256

Location: Baystate Brightwood Health Center, Baystate Mason Square Neighborhood Health Center

Primary Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH)

Purpose: In partnership with Baystate Community Health Centers and UMass Memorial Family Medicine Health Centers, we will study a diverse population of 318 patients with type 2 diabetes (T2DM). The purpose of this research is to see if clinical pharmacists, community health workers, videoconferencing, and continuous glucose monitoring (CGM) improve blood sugar levels and diabetes care. We expect to enroll 186 participants from the Baystate Health site.

Eligibility

Inclusion Criteria:

  • Age 25-75.
  • History of T2DM > 1 year.
  • Speak English or Spanish.
  • A1c ≥ 8% (within past 6 months)
  • Willingness to use continuous glucose monitoring (CGM) and work with a community health worker (including home visits) and clinical pharmacist.

Exclusion Criteria:

  • Plans for weight reduction surgery or prescription weight loss medication (specific for weight loss, not GLP-1).
  • Current, recent, or planned use of CGM.
  • Current use of steroids.
  • Abuse of illicit drugs.
  • Pregnancy (or planned pregnancy).
  • Specific comorbidities (e.g., recent MI, TIA, CVA, malignancy, hemoglobinopathy, severe hypoglycemia, etc.).
  • Psychiatric disorder that may limit ability to perform study tasks
  • Skin changes that preclude use of sensor or allergy to adhesive.
  • Planning to leave geographic area within 12 months or distance from clinical site > 20 miles.
  • Participation in another study.

Dates and Time Commitment

Recruitment Status: Active, Recruiting

Active Date Opened to Enrollment/Recruitment: 06/06/2025

Trial Start Date: 09/27/2024
Trial Expire Date: 03/31/2028
Time Commitment: 18 months

Contact 

Contact Name: Clinical Trials Unit
Contact Phone: (413) 794-6690
Contact Email: teamcgm@umassmed.edu

 

Back to Top